Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa D Aimone

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition testRabindranath Tripathy, Robert J McHugh, Edward R Bacon, et al.
Journal of Medicinal Chemistry|May 19, 2012
A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779Benjamin J Dugan, Diane E Gingrich, Eugen F Mesaros, et al.
Journal of Medicinal Chemistry|August 22, 2008
Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine modelsRobert L Hudkins, James L Diebold, Ming Tao, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinasesCraig A Zificsak, Diane E Gingrich, Henry J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilinesCraig A Zificsak, Jay P Theroff, Lisa D Aimone, et al.
Journal of Medicinal Chemistry|December 7, 2011
Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitorsEugen F Mesaros, Tho V Thieu, Gregory J Wells, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonistsBabu G Sundar, Thomas R Bailey, Derek D Dunn, et al.
Journal of Medicinal Chemistry|August 17, 2016
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)Gregory R Ott, Mangeng Cheng, Keith S Learn, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition testRabindranath Tripathy, Robert J McHugh, Edward R Bacon, et al.
Journal of Medicinal Chemistry|May 19, 2012
A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779Benjamin J Dugan, Diane E Gingrich, Eugen F Mesaros, et al.
Journal of Medicinal Chemistry|August 22, 2008
Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine modelsRobert L Hudkins, James L Diebold, Ming Tao, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinasesCraig A Zificsak, Diane E Gingrich, Henry J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilinesCraig A Zificsak, Jay P Theroff, Lisa D Aimone, et al.
Journal of Medicinal Chemistry|December 7, 2011
Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitorsEugen F Mesaros, Tho V Thieu, Gregory J Wells, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonistsBabu G Sundar, Thomas R Bailey, Derek D Dunn, et al.
Journal of Medicinal Chemistry|August 17, 2016
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)Gregory R Ott, Mangeng Cheng, Keith S Learn, et al.
Pageof 5